| 标题： | 傣医防治拢蒙沙喉（类风湿关节炎）专家共识 |
| title： | Expert consensus on prevention and treatment of LongMengShaHou (rheumatoid arthritis) by Dai medicine |
| 版本： | 原创版 |
| version： | Original |
| 分类： | 专家共识 |
| classification： | Experts consensus |
| 领域： | 综合 |
| field： | Comprehensive guideline |
| 国家和地区： | 中国 |
| Country and region： | China |
| 指南使用者： | 本规范适用于指导民族医医院、中医院、中西医结合医院、综合医院、基层医院等的傣医、中医、中西医结合医务人员，在临床实践中参考本共识，为类风湿关节炎患者提供更加全面和个体化的治疗方案。 |
| Guide users： | This specification is applicable to guide the medical personnel of Dai medicine, traditional Chinese medicine, traditional Chinese medicine and integrated Chinese and Western medicine in ethnic medicine hospitals, Chinese medicine hospitals, integrated Chinese and Western medicine hospitals, general hospitals and primary hospitals, etc., to refer to this Consensus in their clinical practice and to provide patients with rheumatoid arthritis with a more comprehensive and individualized treatment plan. |
| 证据分级方法： | 证据检索与专家共识结合 |
| Evidence grading method： | Evidence search combined with expert consensus |
| 制定单位： | 云南省中医医院（云南省中医药大学第一附属医院）、云南省西双版纳州傣医医院 |
| Formulating unit： | Yunnan Traditional Chinese Medicine Hospital (the First Affiliated Hospital of Yunnan University of Traditional Chinese Medicine) and Xishuangbanna Dai Medicine Hospital |
| 注册时间： | 2024-10-07 |
| Registration time： | |
| 注册编号： | PREPARE-2024CN755 |
| Registration number： | |
| 指南制订的目的： | 傣医防治拢蒙沙喉（类风湿关节炎）具有独特的优势和临床疗效，但目前尚未建立规范的傣医药拢蒙沙喉（类风湿关节炎）专家共识。本专家共识着眼于发挥傣医药特色优势，规范傣医药防治类风湿关节炎临床实践，指导医师临床决策，提升傣医药的影响力和认可度。 |
| Purpose of the guideline： | Dai medicine has unique advantages and clinical efficacy in the prevention and treatment of rheumatoid arthritis, but a standardized expert consensus on the prevention and treatment of rheumatoid arthritis by Dai medicine has not yet been established. This expert consensus aims to give full play to the characteristic advantages of Dai medicine, standardize the clinical practice of Dai medicine in the prevention and treatment of rheumatoid arthritis, guide physicians in clinical decision-making, and enhance the influence and recognition of Dai medicine. |
